Integrin-mediated signaling contributes to gadolinium-containingparticle- promoted cell survival and G 1 to S phase cell cycle transition by enhancing focal adhesion formation

Journal of Biological Inorganic Chemistry

Volumn 17, Issue 3, 2012, Pages 375-385

  Li, Jin Xia ^a   Fu, Li Juan ^a   Yang, Xiao Gai ^a   Wang, Kui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cell proliferation; Focal adhesion; Gadolinium; Integrin; Nephrogenic systemic fibrosis

Indexed keywords

CYCLIN D; GADOLINIUM; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; VINCULIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CYCLE S PHASE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FOCAL ADHESION; G1 PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FLOW CYTOMETRY; FOCAL ADHESIONS; G1 PHASE; GADOLINIUM; INTEGRINS; MICE; NIH 3T3 CELLS; ORGANOMETALLIC COMPOUNDS; S PHASE; SIGNAL TRANSDUCTION;

EID: 84862560330     PISSN: 09498257     EISSN: 14321327     Source Type: Journal    
DOI: 10.1007/s00775-011-0859-7     Document Type: Article

References (63)

1. Wang K, Li R, Cheng Y, Zhu B (1999) Coord Chem Rev 190-192:297-308
2. He ML, Rambeck WA (2000) Arch Tierernahr 53:323-334
3. He ML, Ranz D, Rambeck WA (2001) J Anim Physiol Anim Nutr (Berl) 85:263-270
4. He ML, Wehr U, Rambeck WA (2009) J Anim Physiol Anim Nutr (Berl) 94:86-92
5. Ji Y, Cui M, Wang Y, Zhang X (1985) In: Xu G, Xiao J (eds) New frontiers in rare earth science and applications. Proceedings of the 1st international conference on rare earth development and applications. Science Press, Beijing, pp 700-704
6. Gao J (1999) Sci Technol Food Industry S1:49-52
7. Linsalata P, Morse RS, Ford H, Eisenbud M, Franca EP, de Castro MB, Lobao N, Sachett I, Carlos M (1989) Health Phys 56:33-46
8. Grobner T, Prischl FC (2007) Kidney Int 72:260-264
9. Sanyal S, Marckmann P, Scherer S, Abraham JL (2011) Nephrol Dial Transpl 26:3616-3626
10. Kurtkoti J, Snow T, Hiremagalur B (2008) Nephrology (Carlton) 13:235-241
11. Thakral C, Abraham JL (2009) J Cutan Pathol 36:1244-1254
12. US Food and Drug Administration (2010) Information for healthcare professionals: gadolinium-based contrast agents for magnetic resonance imaging (marketed as Magnevist, Multi-Hance, Omniscan, OptiMARK, ProHance). http://www.fda.gov/Drugs/DrugSafety/ucm142884.htm
13. US Food and Drug Administration (2010) FDA drug safety communication: new warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. http://www.fda.gov/Drugs/DrugSafety/ucm223966.htm
14. Stratta P, Canavese C, Quaglia M, Fenoglio R (2009) Rheumatology (Oxf) 49:821-823
15. Swaminathan S, High WA, Ranville J, Horn TD, Hiatt K, Thomas M, Brown HH, Shah SV (2008) Kidney Int 73:1413-1418
16. Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, Campbell ME, Hauschka PV, Hannigan RE (2009) Metallomics 1:479-488
17. Idee JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C (2008) Toxicology 248:77-88
18. Perazella MA (2007) Clin J Am Soc Nephrol 2:200-202
19. Bucala R (2008) J Am Coll Radiol 5:36-39
20. Li J-X, Liu J-C, Wang K, Yang X-G (2010) J Biol Inorg Chem 15:547-557
21. Fu LJ, Li JX, Yang XG, Wang K (2009) J Biol Inorg Chem 14:219-227
22. Edward M, Quinn JA, Burden AD, Newton BB, Jardine AG (2010) Radiology 256:735-743
23. Bhagavathula N, Dame MK, Dasilva M, Jenkins W, Aslam MN, Perone P, Varani J (2010) Invest Radiol 45:769-777
24. Varani J, DaSilva M, Warner RL, Deming MO, Barron AG, Johnson KJ, Swartz RD (2009) Invest Radiol 44:74-81
25. Kumar A, Marques M, Carrera AC (2006) Mol Cell Biol 26:9116-9125
26. Kim SE, Choi KY (2007) Cell Signal 19:1554-1564
27. Tzukert K, Gorodestky R, Avrahami I, Krasny L, Shimony N, Elkin G, Nettelbeck DM, Haviv YS (2008) Cancer Lett 272:345-354
28. Slater TF, Sawyer B, Straeuli U (1963) Biochim Biophys Acta 77:383-393
29. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR (1991) Cancer Res 51:2515-2520
30. Kulkarni GV, McCulloch CA (1994) J Cell Sci 107(5):1169-1179
31. Zhang R, Lu Y, Ye L, Yuan B, Yu S, Qin C, Xie Y, Gao T, Drezner MK, Bonewald LF, Feng JQ (2011) J Bone Miner Res 26:1047-1056
32. Yamazaki M, Ozono K, Okada T, Tachikawa K, Kondou H, Ohata Y, Michigami T (2010) J Cell Biochem 111:1210-1221
33. Habibovic P, Barralet JE (2011) Acta Biomater 7:3013-3026
34. Zhang Y, Fu LJ, Li JX, Yang XG, Yang XD, Wang K (2009) Biometals 22:511-519
35. Bakolitsa C, Cohen DM, Bankston LA, Bobkov AA, Cadwell GW, Jennings L, Critchley DR, Craig SW, Liddington RC (2004) Nature 430:583-586
36. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C (2007) J Cell Biol 179:1043-1057
37. Bois PRJ, O'Hara BP, Nietlispach D, Kirkpatrick J, Izard T (2006) J Biol Chem 281:7228-7236
38. Hynes RO (1992) Cell 69:11-25
39. Miranti CK, Brugge JS (2002) Nat Cell Biol 4:E83-E90
40. Aplin AE, Short SM, Juliano RL (1999) J Biol Chem 274:31223-31228
41. Defilippi P, Olivo C, Tarone G, Mancini P, Torrisi MR, Eva A (1997) Oncogene 14:1933-1943
42. Guan JL (2010) IUBMB Life 62:268-276
43. van Nimwegen MJ, van de Water B (2007) Biochem Pharmacol 73:597-609
44. Ilic D, Furuta T, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T, Aizawa S (1995) Nature 377:539-544
45. Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Ronde P (2005) J Cell Sci 118:4415-4425
46. Wagner S, Storbeck CJ, Roovers K, Chaar ZY, Kolodziej P, McKay M, Sabourin LA (2008) PLoS One 3:9
47. Tomar A, Schlaepfer DD (2009) Curr Opin Cell Biol 21:676-683
48. Clapham DE (2007) Cell 131:1047-1058
49. Lail-Trecker MR, Hanrahan CJ, White BA (1996) Endocrine 5:341-349
50. Hofmann C, Obermeier F, Artinger M, Hausmann M, Falk W, Schoelmerich J, Rogler G, Grossmann J (2007) Gastroenterology 132:587-600
51. Khurana A, Runge VM, Narayanan M, Greene JF Jr, Nickel AE (2007) Invest Radiol 42:139-145
52. Penfield JG, Reilly RF (2008) Semin Dial 21:129-134
53. Cabella C, Crich SG, Corpillo D, Barge A, Ghirelli C, Bruno E, Lorusso V, Uggeri F, Aime S (2006) Contrast Media Mol Imaging 1:23-29
54. Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ (2008) Invest Radiol 43:817-828
55. Takagi J (2007) Curr Opin Cell Biol 19:557-564
56. Krukonis ES, Isberg RR (2000) Cell Microbiol 2:219-230
57. Humphries MJ (2000) Biochem Soc Trans 28:311-339
58. Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK (2004) Mol Cell Biol 24:8586-8599
59. Schneller M, Vuori K, Ruoslahti E (1997) EMBO J 16:5600-5607
60. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR (2007) J Cell Physiol 213:649-653
61. Lee JW, Juliano R (2004) Mol Cells 17:188-202
62. Kay J, High WA (2008) Arthritis Rheum 58:2543-2548
63. Swaminathan S, Arbiser JL, Hiatt KM, High W, Abul-Ezz S, Horn TD, Shah SV (2010) J Am Acad Dermatol 62:343-345